Redmile Group
Redmile Group is a healthcare-focused alternative asset management firm based in San Francisco, California. Founded in 2007 by Jeremy Green, the firm specializes in venture capital, private equity, and hedge fund strategies, primarily targeting the biotechnology, therapeutics, life sciences, medical devices, and healthcare services sectors. With approximately $4.7 billion in assets under management, Redmile Group emphasizes investments in clinical-stage biotechnology companies. The firm offers a range of financial services, including venture capital investments in early-stage healthcare compa
Investing activity
Redmile Group appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $25M, and led 1 of them. The rounds are mostly Seed, with a median round size of $25M. The most recent is Bios Life (Seed, $25M, Aug 2026).
Redmile Group most often invests alongside Kindred Capital and Vsquared Ventures, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Redmile Group
What AI companies has Redmile Group invested in?
Redmile Group's AI investments include Bios Life. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Redmile Group based?
Redmile Group is based in San Francisco, California, United States.
What stage does Redmile Group invest at?
In the rounds tracked on AI Lounge, Redmile Group has invested at Seed, with a median round of $25M. Redmile Group led 1 of those rounds.
Who does Redmile Group co-invest with?
Redmile Group's most frequent co-investors on AI Lounge are Kindred Capital (1 deal) and Vsquared Ventures (1 deal).
How can founders reach Redmile Group?
Founders on AI Lounge can see Redmile Group's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Redmile Group to their Investor Pipeline to track the conversation.